Exos Asset Management’s Jackson Acquisition Company Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 RJAC.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$0 Hold
239
﹤0.01% 350
2022
Q1
$0 Buy
+239
New +$85 ﹤0.01% 382

Other funds holding RJAC.WS

Exos Asset Management's RJAC.WS Position: Q2 2022 in Review

Exos Asset Management held its Jackson Acquisition Company Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 (RJAC.WS) position steady in Q2 2022 at 239 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #350.

Exos Asset Management first reported a position in RJAC.WS in Q1 2022 and has held it in 2 quarters since. 35 funds tracked by Wall St. Rank hold RJAC.WS as of Q2 2022.

  • Exos Asset Management held 239 shares of Jackson Acquisition Company Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 worth $0 as of Q2 2022.
  • Exos Asset Management left its Jackson Acquisition Company Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 share count unchanged in Q2 2022.
  • Jackson Acquisition Company Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 made up ﹤0.01% of Exos Asset Management's portfolio in Q2 2022, its #350 holding.
  • Exos Asset Management first reported a position in Jackson Acquisition Company Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 in Q1 2022 and has held it in 2 quarters since.
  • 35 funds tracked by Wall St. Rank held Jackson Acquisition Company Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 as of Q2 2022.

Based on Exos Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.